Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11390884
Optimized CRISPR/cas9 systems and methods for gene editing in stem cells
granted -
US 11389481
Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19
granted -
US 11390921
Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
granted -
US 11385233
Methods of depleting malignant T-cells
granted -
US 11384335
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11382932
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11376318
Methods of preparing anti-human papillomavirus antigen t cells
granted -
US 11377646
Modified cells comprising CRISPR systems
granted -
US 11377659
Short hairpin RNA (shRNA734) and use of same to positively select and eliminate genetically modified cells
granted -
US 11369683
Systems and methods for targeted imaging and ablation of cardiac cells
granted -
US 11370825
Polypeptides, cells, and methods involving engineered CD16
granted -
US 11365394
Enhanced immune effector cells and use thereof
granted -
US 11357860
Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
granted -
US 11352607
Genomic engineering of pluripotent cells
granted -
US 11344578
Immune cells expressing engineered antigen receptors
granted -
US 11344577
Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted -
US 11344615
Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells
granted -
US 11339198
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted -
US 11338032
Methods of preparing anti-human papillomavirus antigen T cells
granted -
US 11331385
Methods of preparing anti-human papillomavirus antigen T cells
granted -
US 11332716
Methods and compositions for producing pancreatic beta cells
granted -
US 11325973
Modulation of stimulatory and non-stimulatory myeloid cells
granted -
US 11306287
Method of generating skeletal muscle stem cells from pluripotent cells
granted -
US 11306288
Methods for preparing therapeutically active cells using microfluidics
granted